Hubei Province Tahe Hospital
Hubei Province Tahe Hospital
Taihe, Hubei, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, hepatocellular carcinoma, liver disorder, portal hypertension | Not yet recruiting | Phase 2 | 2026-01-20 | NCT07350070 |